Opus Genetics (IRD) Institutional Ownership $1.36 -0.02 (-1.09%) As of 02:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Opus Genetics (NASDAQ:IRD)CurrentInstitutional OwnershipPercentage14.97%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$9.45MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$70.13K Get IRD Insider Trade Alerts Want to know when executives and insiders are buying or selling Opus Genetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data IRD Institutional Buying and Selling by Quarter Opus Genetics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Opaleye Management Inc.1,220,000$1.15M0.2%+3.8%2.045% 8/15/2025 Mink Brook Asset Management LLC1,197,616$1.13M1.0%+47.8%2.007% 8/15/2025 Bridgeway Capital Management LLC42,065$40K0.0%-63.9%0.071% 8/14/2025 Nantahala Capital Management LLC3,345,923$3.15M0.1%+6.0%5.608% 8/14/2025 Voss Capital LP541,159$510K0.0%+260.8%0.907% 8/12/2025 BIOS Capital Management LP3,683,429$3.46M4.8%+270.1%6.174% 5/16/2025AWM Investment Company Inc.524,245$515K0.1%N/A1.153% 5/15/2025Nantahala Capital Management LLC3,157,895$3.10M0.1%N/A6.943% 5/15/2025Royal Bank of Canada304,123$299K0.0%N/A0.669% 5/14/2025BIOS Capital Management LP995,249$977K1.2%N/A2.188% 5/14/2025Comerica Bank30,000$29K0.0%N/A0.066% 5/14/2025Mink Brook Asset Management LLC810,080$795K0.8%N/A1.781% 5/14/2025Voss Capital LP150,000$147K0.0%N/A0.330% 5/12/2025Virtu Financial LLC26,275$26K0.0%N/A0.058% 5/5/2025Kestra Private Wealth Services LLC48,341$47K0.0%N/A0.106% 5/2/2025Apollon Wealth Management LLC28,089$28K0.0%N/A0.062% (Data available from 1/1/2016 forward) IRD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IRD shares? During the previous two years, 12 institutional investors and hedge funds held shares of Opus Genetics. The most heavily invested institutionals were BIOS Capital Management LP ($3.46M), Nantahala Capital Management LLC ($3.15M), Opaleye Management Inc. ($1.15M), Mink Brook Asset Management LLC ($1.13M), AWM Investment Company Inc. ($515K), Voss Capital LP ($510K), and Royal Bank of Canada ($299K).Learn more on Opus Genetics' institutional investors. What percentage of Opus Genetics' stock is owned by institutional investors? 14.97% of Opus Genetics' stock is owned by institutional investors. Learn more on IRD's institutional investor holdings. Which institutional investors have been buying Opus Genetics' stock? Of the 11 institutional investors that purchased Opus Genetics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BIOS Capital Management LP ($3.68M), Nantahala Capital Management LLC ($3.35M), Mink Brook Asset Management LLC ($1.20M), Voss Capital LP ($541.16K), AWM Investment Company Inc. ($524.25K), Royal Bank of Canada ($304.12K), and Kestra Private Wealth Services LLC ($48.34K). How much institutional buying is happening at Opus Genetics? Institutional investors have bought a total of 9,774,200 shares in the last 24 months. This purchase volume represents approximately $9.45M in transactions. Which of Opus Genetics' major shareholders have been selling company stock? The following institutional investors have sold Opus Genetics stock in the last 24 months: Bridgeway Capital Management LLC ($74.44K). How much institutional selling is happening at Opus Genetics? Institutional investors have sold a total of 74,436 shares in the last 24 months. This volume of shares sold represents approximately $70.13K in transactions. Related Companies Larimar Therapeutics Major Shareholders Tectonic Therapeutic Major Shareholders Amarin Major Shareholders Upexi Major Shareholders Galectin Therapeutics Major Shareholders Foghorn Therapeutics Major Shareholders Ocugen Major Shareholders scPharmaceuticals Major Shareholders Monte Rosa Therapeutics Major Shareholders Capricor Therapeutics Major Shareholders This page (NASDAQ:IRD) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opus Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Opus Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRD Stock Alerts